Journals / Türk Oftalmoloji Dergisi / 2019 / Cilt: 49 - Sayı: 1

Etiological and Clinical Characteristics of HLA-B27-associated Uveitis in a Tertiary Referral Center

Üçüncü Basamak Merkeze Başvuran HLA-B27 İlişkili Üveit Olgularının Etiyolojik ve Klinik Özellikleri

Pages
10–14
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Visual prognosis is good despite the complications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: To investigate the demographic, etiologic, and clinical features of HLA-B27-associated uveitis.
📊
Key Findings & Data:Materials and Methods: The clinical records of 91 patients diagnosed with HLA-B27-associated uveitis at the Ulucanlar Eye Training and Research Hospital between the years of 2005 and 2016 were reviewed.
💡
Conclusion & Impact:Visual prognosis is good despite the complications.
🔬Design:Review & Systematic Survey
📍Scope:2005 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: To investigate the demographic, etiologic, and clinical features of HLA-B27-associated uveitis. Materials and Methods: The clinical records of 91 patients diagnosed with HLA-B27-associated uveitis at the Ulucanlar Eye Training and Research Hospital between the years of 2005 and 2016 were reviewed. Each patient’s presenting complaints, best-corrected visual acuities in first and last visits, biomicroscopic and fundoscopic examination findings, frequency and seasonal distribution of attacks, and demographic data such as age and sex were noted. Therapeutic approaches, duration of follow-up, and complications were analyzed. Results: A total of 91 patients (179 eyes) aged 19-82 years (mean age 46.52±13.06 years) were included. Forty-three patients (47.3%) were female and 48 (52.7%) were male. Bilateral involvement was observed in 44 (48.4%) and unilateral involvement was observed in 47 (51.6%) patients. The most frequent complaint was redness (67%), followed by decreased and/or blurred vision (50.5%). The mean follow-up time was 38.2 months (range, 1-245 months). Anterior uveitis was most common anatomical subtype, seen in 86 (94.5%) of the patients. Mean number of attacks was 1.93±1.45 per patient-year and a significantly higher number of uveitis attacks (47%) occurred in winter. Twenty-four patients (26.3%) were diagnosed with ankylosing spondylitis. Fibrinous uveitis was detected in 36 patients (39.5%). Posterior synechia developed in 41 (22.9%) and hypopyon developed in 7 (3.9%) eyes. The most common complications were cataract (n=12, 6.7%) and ocular hypertension (n=15, 8.3%). Conclusion: Ninety-one (6.3%) of the 1422 patients followed in our uvea clinic were diagnosed with HLA-B27-associated uveitis. HLA-B27-associated uveitis is characterized by acute, recurring sudden-onset iridocyclitis with a moderate to severe amount of fibrin and cells in the anterior chamber, and is easily treatable. Visual prognosis is good despite the complications.

Özet

Amaç: HLA-B27 ile ilişkili üveitlerin demografik, etiyolojik ve klinik özelliklerini araştırmaktır.Gereç ve Yöntem: Ulucanlar Göz Eğitim ve Araştırma Hastanesi’nde 2005-2016 yılları arasında HLA-B27 ile ilişkili üveit tanısıalan 91 hastanın klinik kayıtları gözden geçirildi. Hastaların başvuru şikayeti; ilk ve son vizit en iyi düzeltilmiş görme keskinlikleri,biyomikroskobik ve fundoskopik muayene bulguları, atakların sıklığı ve mevsimsel dağılımı ile yaş ve cinsiyet gibi demografik verilerikaydedildi. Tedavi yaklaşımları, takip süreleri ve komplikasyonlar analiz edildi.Bulgular: Yaşları 19 ile 82 arasında değişen (46,52±13,06 yıl) 91 hastanın 179 gözü çalışmaya dahil edildi. Hastaların 43’ü (%47,3)kadın, 48’i (%52,7) erkekti. Olguların 44’ünde (%48,4) bilateral tutulum, 47’sinde (%51,6) unilateral tutulum mevcuttu. En sıksaptanan başvuru şikayeti kızarıklık (%67) ve onu takiben azalmış görme keskinliği (%50,5) idi. Ortalama takip süresi 38,2 (6-245) ayidi. 86 olguda (%94,5) saptanan ön üveit en sık görülen anatomik tipti. Ortalama atak sayısı 1,93±1,45/hasta-yıldı ve atakların önemliölçüde kış aylarında (%47) gerçekleştiği görüldü. Yirmi dört hasta (%26,3) ankilozan spondilit tanısı aldı. Otuz altı (%39,5) hastadafibrinöz üveit saptandı. Kırk bir (%22,9) gözde posterior sineşi ve 7 (%3,9) gözde hipopyon gelişti. Takip süresince en sık görülenkomplikasyonlar katarakt (n=12, %6,7) ve oküler hipertansiyon (n=15, %8,3) idi.Sonuç: Uvea kliniğimizde takip edilen 1422 hastanın 91’i (%6,3) HLA-B27 ile ilişkili üveit tanısı almıştır. HLA-B27 ile ilişkili üveitani başlangıçlı akut, tekrarlayan iridosiklit, ön kamarada orta ve şiddetli miktarda fibrin ve hücrelerle karakterizedir ve kolayca tedaviedilebilir. Komplikasyonlara rağmen görme prognozu iyidir.

🔖

Cite This Article

ÖZDAL, M. P. Ç., İNANÇ, M., ŞİMŞEK, M. (2022). Etiological and Clinical Characteristics of HLA-B27-associated Uveitis in a Tertiary Referral Center. Türk Oftalmoloji Dergisi, Cilt: 49 - Sayı: 1, 10–14. https://ajindex.com/articles/637752

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Suttorp-Schulten MS, Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol. 1996;80:844-848
  2. Jabs DA, Nussenblatt RB, Rosenbaum JT; Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509-516
  3. Tomkins-Netzer O, Talat L, Bar A, Lula A, Taylor SR, Joshi L, Lightman S. Long-term clinical outcome and causes of vision loss in patients with uveitis. Ophthalmology. 2014;121:2387-2392
  4. Chang JH, McCluskey PJ, Wakefield D. Acute anterior uveitis and HLA-B27. Surv Ophthalmol. 2005;50:364-388
  5. Ramsay A, Lightman S. Hypopyon uveitis. Surv Ophthalmol. 2001;46:1-18
  6. Özdal PÇ. Ön üveitler. Türkiye Klinikleri J Ophthalmol-Special Topics 2008;1:27-37
  7. Wakefield D, Chang JH, Amjadi S, Maconochie Z, Abu El-Asrar A, McCluskey P. What is new HLA-B27 acute anterior uveitis? Ocul Immunol Inflamm. 2011;19:139-144
  8. Brewerton DA, Caffrey M, Nicholls A, Walters D, James DC. Acute anterior uveitis and HLA 27. Lancet. 1973;302:994-996
  9. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. Lancet. 1973;301:904-907
  10. Brewerton DA, Caffrey M, Nicholls A, Walters D, James DC. HLA 27 and arthropathies associated with ulcerative colitis and psoriasis. Lancet. 1974;303:956-958
  11. Brewerton DA, Caffrey M, Nicholls A, Walters D, Oates JK, James DC. Reiter’s disease and HL-A 27. Lancet. 1973;302:996-998
  12. Yalçındağ FN, Özdal PC, Özyazgan Y, Batıoğlu F, Tugal-Tutkun I; BUST Study Group. Demographic and Clinical Characteristics of Uveitis in Turkey: The First National Registry Report. Ocul Immunol Inflamm. 2016;26:17-26
  13. Kazokoglu H, Onal S, Tugal-Tutkun I, Mirza E, Akova Y, Ozyazgan Y, Soylu M, Batioglu F, Apaydin C. Demographic and clinical features of uveitis in tertiary centers in Turkey. Ophthalmic Epidemiol. 2008;15:285-293
  14. Tuncer S, Adam YS, Urgancioglu M, Tugal-Tutkun I. Clinical features and outcomes of HLA-b27-positive and HLA-B27-negative acute anterior uveitis in a Turkish patient population. Ocul Immunol Inflamm. 2005;13:367-373. 15. van der Veer EG, Keunen JE, Rothova A. Severe HLA B27- associated uveitis complicated by hypotony, serous retinal detachment, and ciliochoroidal effusion. Ocul Immunol Inflamm. 2014;22:23-26
  15. Roe R, Branco BC, Cunningham ET Jr. Hypotony maculopathy in a patient with HLA-B2